What Has the MHRA Announced
LillyDirect is a registered trademark owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates
My husband was so supportive, she said
Frequently Asked Questions (FAQs) Learn more about Ozempic and blindness with answers to these frequently asked questions
Mechanism of Action The mechanism of action of Tirzepatide is defined by its function as a biased agonist at two distinct G-protein coupled receptors (GPCRs): the glucagon-like peptide-1 receptor (GLP-1R) and the glucose-dependent insulinotropic polypeptide receptor (GIPR)
June 1, 2026: Over 100 Lawsuits in the GLP-1 NAION MDL, Ozempic Patient Sues After Becoming Blind from NAION The GLP-1 NAION multidistrict litigation now has 110 lawsuits in it, as of June 1, 2026